Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab

Therapeutic drug monitoring (TDM) of anti-TNF-α is an important tool in clinical practice for inflammatory diseases. In this study, we have evaluated the performance of several assays for drug and antidrug antibodies (ADA) measurement in the serum. 50 sera from patients treated with infliximab (IFX)...

Descripción completa

Detalles Bibliográficos
Autores principales: Rissel, Florian, Cazaubon, Yoann, Saffar, Syrine, Altwegg, Romain, Artasone, Mélanie, Lozano, Claire, Vincent, Thierry, Jentzer, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299129/
https://www.ncbi.nlm.nih.gov/pubmed/37373525
http://dx.doi.org/10.3390/ijms241210379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299129/
https://www.ncbi.nlm.nih.gov/pubmed/37373525
http://dx.doi.org/10.3390/ijms241210379

Ejemplares similares